If you have MDS, a type of blood cancer called myelodysplastic syndrome, you’re part of a rare group of people with the diagnosis. But research is ongoing. Many clinical trials are seeking new ...

Myelodysplastic syndrome (MDS) can be difficult to diagnose ... A very basic blood test called a CBC can determine whether the numbers of various types of blood cells are within normal ranges. CBC ...

What type of MDS do I have ... A guide for patients and families,” “Myelodysplastic Syndrome Prognostic Scores,” “If you Have Myelodysplastic Syndrome,” “Psychosocial Support Options ...

Every aspect of your care — diagnosis, treatment, recovery, support — will be tailored to meet your particular needs. Beyond the many other health issues it causes, smoking is a serious risk factor ...

Myelodysplastic syndromes (MDS) are clonal disorders of ... to disease progression to acute myeloid leukemia. Various cell types contribute to dysregulation of immune responses in MDS.

Myelodysplastic syndrome (MDS) is a rare haematological cancer characterized by abnormal development and maturation (dysplasia) of immature blood cells in the bone marrow, resulting in varying ...

Interferon gamma-1b is under clinical development by Amgen and currently in Phase II for Myelodysplastic Syndrome.

Myelodysplastic syndromes (MDS) is a group of closely related ... 5 It’s not a one-size-fits-all type of diagnosis, says Dr.

Azacitidine is under clinical development by Bristol-Myers Squibb and currently in Phase II for Essential Thrombocythemia.